The global antinuclear
antibody test market is foreseen to grow at 11.8%, from USD 1.24 Billion in
2021 to USD 3.03 Billion in 2029. High incidence of autoimmune diseases, increasing
population, growth in healthcare expenditure, and growth in the number of
individuals covered under medical insurance are the factors to growing the global antinuclear
antibody test market. However, stringent regulations for the approval of
medical devices, implementation of excise duty on medical devices in the U.S. Have
seen restraint in the market growth for the estimated period.
Market Definition
What is Antinuclear
antibody test?
An antinuclear
antibody test checks to see if you have an autoimmune disorder, a condition
where the immune system attacks healthy cells.
Market Overview
The antinuclear
antibody test market research study helps to thoroughly understand the current
trend in the market, competitive analysis of the players in the emerging
market. Moreover, the DRO in the antinuclear antibody test market offers
valuable perspicuity and a current scenario for making the right decision. The
research study covers the eminent players in the market with a detailed
analysis of the company and a financial overview containing their net sales,
business mix and geographical reach. It mainly focuses on the key developments of
the products/services offered by the company in recent years. Besides, we at
Zettabyte have the expertise to analyse the global antinuclear antibody test
market player's competitive landscape, helping the client comprehend their
specific strategic growth approaches.
Antinuclear
antibody test market study by "Zettabyte Analytics" offers details
about the market scope, market segmentation, technological advancement in the antinuclear
antibody test market and highlights the optimistic, competitive landscape and
trends enduring over the years.
Major players in
the antinuclear antibody test Market include Alere Inc.(Abbott Laboratories),
Antibodies Inc., Becton Dickinson, Bio-Rad Laboratories, Inc., BioVision Inc.,
ERBA Diagnostics Inc., Euroimmun AG, F. Hoffmann-La Roche Ltd., Grifols SA, Immuno
Concepts Inc., Inova Diagnostics Inc., Orgentec Diagnostika GmbH, PerkinElmer
Inc., Quidel Corporation, Thermo Fisher Scientific, Inc., Trinity Biotech PLC,
Zeus Scientific, Inc.
COVID-19 Impact on Global Antinuclear
Antibody Test Market
The global impact
of COVID-19 has lost millions of lives with a massive cost to the healthcare
system. Moreover, the treatment cost for patients with COVID-19 has also had a
financial impact globally. The impact of COVID-19 on the Antinuclear antibody
test Market has forced the companies to change their sourcing, pricing, and
promotion strategies. The Antinuclear antibody test Market players are seen
focusing more on optimizing the E-commerce networks with the rising innovations
in the digital sector, which are creating new business models for the
healthcare industry player.
Research Scope
The report
provides market value for the base year 2021 and a yearly forecast from 2022 to
2029 in revenue (USD Million/ Billion). The market for each segment is present
in North America, Europe, Asia Pacific, Latin America, Middle East &
Africa, and the regional basis for the forecast mentioned above.
Key industry
dynamics, regulatory scenarios, major material dynamics and Antinuclear
antibody test' future markets are analyzed to understand their impact on demand
for the forecast period. Growth rates have been estimated using correlation,
regression and time-series analysis.
Market Segmentation
For the purpose
of this report, the global antinuclear antibody test market is segmented on the
basis of product type, disease type, technique, end use and region:
Product Type
|
Reagents & Assay Kits
|
Systems
|
Software & Services
|
|
|
Disease Type
|
Rheumatoid Arthritis
|
Systemic Lupus Erythematosus
|
Sjögren’s Syndrome
|
Scleroderma
|
Other Diseases
|
|
|
Technique
|
ELISA
|
Immunofluorescence Assay
|
Multiplex Assay
|
|
|
End Use
|
Hospitals
|
Clinical Laboratories
|
Physician Office Laboratories
|
Others End Users
|
Product Type Outlook:
On the basis of
Product Type, the market is segmented into Reagents & Assay Kits, Systems,
Software & Services.
Figure 1 - Antinuclear antibody test Market,
By Product Type (Market Size And Forecast By Value - USD Million, 2021 &
2029)